| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 126,355 | 133,438 |
| Net increase in cash and cash equivalents and restricted cash | 1,276 | 22,032 |
| Cash and cash equivalents at beginning of period | 59,556 | - |
| Cash and cash equivalents at end of period | 60,832 | - |
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)